Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Retained Earnings (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Retained Earnings for 3 consecutive years, with -$292.2 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 37.99% to -$292.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$292.2 million through Dec 2025, down 37.99% year-over-year, with the annual reading at -$292.2 million for FY2025, 37.99% down from the prior year.
  • Retained Earnings hit -$292.2 million in Q4 2025 for Camp4 Therapeutics, down from -$251.9 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$160.0 million in Q4 2023 to a low of -$292.2 million in Q4 2025.
  • Historically, Retained Earnings has averaged -$225.0 million across 3 years, with a median of -$224.2 million in 2025.
  • Biggest YoY gain for Retained Earnings was 26.9% in 2025; the steepest drop was 37.99% in 2025.
  • Year by year, Retained Earnings stood at -$160.0 million in 2023, then crashed by 32.38% to -$211.8 million in 2024, then crashed by 37.99% to -$292.2 million in 2025.
  • Business Quant data shows Retained Earnings for CAMP at -$292.2 million in Q4 2025, -$251.9 million in Q3 2025, and -$236.8 million in Q2 2025.